Efficacy of PErioperative PEmbrolizumab Treatment in Patients With Resectable Metastases From Kidney Cancer
Clinical trial NCT05578664 · UNKNOWN
Trial details
- NCT number
- NCT05578664
- Sponsor
- Consorzio Oncotech
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-14
- Primary completion
- 2024-10-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.